Skip to main content

Table 1 Identification independent clinical factors associated with LUAD prognosis

From: Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma

Clinical characteristics

Uni-variable cox

Multi-variable cox

HR (95% CI)

P value

HR (95% CI)

P value

Age(years, meanā€‰Ā±ā€‰sd)

1.009[0.994ā€“1.024]

2.64E-01

-

-

Gender(Male/Female)

1.060[0.792ā€“1.418]

6.95E-01

-

-

Pathologic M(M0/M1)

2.111[1.232ā€“3.616]

5.36E-03

0.236[0.0515ā€“1.085]

6.36E-02

Pathologic N(N0/N1/N2/N3)

1.710[1.443ā€“2.027]

2.00E-10

0.888[0.538ā€“1.464]

6.41E-01

Pathologic T(T1/T2/T3/T4)

1.550[ 1.289ā€“1.863]

3.10E-06

1.194[0.884ā€“1.613]

2.48E-01

Pathologic stage(I/II/III/IV)

1.679[1.463ā€“1.928]

2.94E-14

2.135[1.206ā€“3.780]

9.24E-03

Tumor recurrence(Yes/No/-)

2.392[1.700-3.367]

2.44E-07

2.475[1.638ā€“3.738]

1.68E-05

Smoking history(Yes/No)

0.765[ 0.542ā€“1.081]

1.29E-01

-

-